The cardiovascular system: the appearance of symptoms of heart failure, violation of atrioventricular conduction, arrhythmias, bradycardia, marked decrease in blood pressure, orthostatic hypotension, palpitations.
Central nervous system: dizziness, decreased ability to concentrate, drowsiness, depression, hallucinations, lethargy, fatigue, headache, weakness, insomnia, nightmares, anxiety, confusion or short-term memory loss, paresthesia in the extremities (in patients with "intermittent" lameness and Raynaud's syndrome), muscle weakness, convulsions.
Gastrointestinal tract: dry mouth, nausea, vomiting, diarrhea, abdominal pain, constipation, taste change.
Respiratory system: dyspnea, bronchospasm, apnea, nasal congestion.
Hematologic reactions: thrombocyte purpura, anemia (aplastic), thrombosis.
Endocrine system: gynecomastia, decreased potency, decreased libido, hyperglycemia (in patients with insulin-dependent diabetes mellitus), hypoglycemia (in patients receiving insulin), hypothyroid status.
Metabolic reactions: hyperlipidemia.
Skin reactions: urticaria, dermatitis, itching, photosensitivity, increased sweating, skin hyperemia, exacerbation of psoriasis, reversible alopecia.
Sense organs: impaired vision, decreased secretion of tear fluid, dryness and soreness of the eyes, conjunctivitis.
Influence on the fetus: intrauterine growth retardation, hypoglycemia, bradycardia.
Laboratory indicators: agranulocytosis, leukopenia, increased activity of "hepatic" enzymes, bilirubin level.
Other: back pain, arthralgia, withdrawal syndrome (increased angina attacks, increased blood pressure).